biopsies in some patients. None of our 13 patients with MM or other dysglobulinaemias had HHV-8 antibodies (Table 1) , whereas all 10 control patients did. HHV-8 DNA sequences could not be detected in PBMCs samples. At day 12 of culture, 20-60% CD1a
− dendritic cells were generated from the PBMCs of patients with MM. PCR amplification for HHV-8 was negative in all samples tested ( Table 1) . The KS330 233 and v-IL-6 sequences of HHV-8 could not be detected in any of the bone marrow samples, either in total BMMCs, in fresh BM biopsies, or in LTBMSCs whatever the duration of culture (10, 15 and 20 days) ( Table 1 ). In addition, patient 10 with a POEMS syndrome and patient 11 with a primary AL amyloidosis were also negative for HHV8 in per- ipheral and bone marrow compartments (Table 1) . PCR performed on BM biopsies from two patients with WM (patients 12 and 13) were also negative for HHV-8, and none of these patients (patients 10, 11, 12, 13) elicited antibody reactivity directed against the HHV-8 LANA protein.
In this study, serological results confirm our previous report 5 and indicate that none of our MM patients exhibit antibody reactivity to the LANA of HHV-8. 
